Evidence map›Paper›PMID 32968894›Full record

ArticlePharmaceutical research2020

A Biopredictive In Vitro Approach for Assessing Compatibility of a Novel Pediatric Hydrocortisone Drug Product within Common Pediatric Dosing Vehicles.

Erik Wollmer, Frank Karkossa, Lisa Freerks, Anna-Elena Hetberg, Greg Neal, John Porter, Martin J Whitaker, Daniel Margetson, Sandra Klein

Open access · hybridAbstract read
In one paragraph

Article in Pharmaceutical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Erik WollmerDepartment of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
Frank KarkossaDepartment of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
Lisa FreerksDepartment of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
Anna-Elena HetbergDepartment of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany.
Greg NealDiurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.
John PorterDiurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.
Martin J WhitakerDiurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.
Daniel MargetsonDiurnal Limited, Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.
Sandra KleinDepartment of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, Center of Drug Absorption and Transport (C_DAT), University of Greifswald, Felix-Hausdorff-Street 3, 17489, Greifswald, Germany. Sandra.Klein@uni-greifswald.de.ORCID http://orcid.org/0000-0001-7356-5780
Diurnal (United Kingdom) · GBUniversität Greifswald · DEUniversitätsmedizin Greifswald · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe objective of the present work was to screen whether a novel pediatric hydrocortisone granule formulation can be co-administered with common food matrices and liquids.

methodsPediatric hydrocortisone granules were studied using a biopredictive in vitro approach. Experiments included an in situ chemical compatibility study of active ingredient and drug product with liquid dosing vehicles and soft foods commonly ingested by infants, pre-school- and school children. Drug solubility and stability experiments in the different vehicle types and, drug release/dissolution experiments mimicking age-related pediatric gastric conditions after administering the hydrocortisone granules together with the dosing vehicles and after different exposure/mixing times were performed.

resultsIn the simulated dosing scenarios applied in dissolution experiments, in vitro dissolution in gastric conditions was rapid and complete. Results of the chemical compatibility/stability studies indicated that mixing with the different dosing vehicles studied should not be an issue regarding drug degradation products.

conclusionsA novel in vitro approach ensuring a proper risk assessment of the use of dosing vehicles in the administration of pediatric dosage forms was established and applied to a novel pediatric hydrocortisone drug product. The studied dosing vehicles were shown to not alter performance of the drug product and are thus considered suitable for administration with hydrocortisone granules. Graphical abstract.

Indexed as

Food-Drug InteractionsAdministration, OralChildChild, PreschoolDrug CompoundingDrug LiberationDrug StabilityFoodHumansHydrocortisoneInfantIn Vitro TechniquesPediatricsPharmaceutical PreparationsSolubilityHydrocortisonePharmaceutical Preparationsbiorelevant dissolutiongastric medialiquidsquality assessmentsoft foods

Identifiers

PMID32968894
PMCPMC7511475
OpenAlexW3088441571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.